These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 7712490

  • 1. Expression of brain-derived neurotrophic factor and p145TrkB affects survival, differentiation, and invasiveness of human neuroblastoma cells.
    Matsumoto K, Wada RK, Yamashiro JM, Kaplan DR, Thiele CJ.
    Cancer Res; 1995 Apr 15; 55(8):1798-806. PubMed ID: 7712490
    [Abstract] [Full Text] [Related]

  • 2. Brain-derived neurotrophic factor protects neuroblastoma cells from vinblastine toxicity.
    Scala S, Wosikowski K, Giannakakou P, Valle P, Biedler JL, Spengler BA, Lucarelli E, Bates SE, Thiele CJ.
    Cancer Res; 1996 Aug 15; 56(16):3737-42. PubMed ID: 8706017
    [Abstract] [Full Text] [Related]

  • 3. Prognostic and biological role of neurotrophin-receptor TrkA and TrkB in neuroblastoma.
    Eggert A, Ikegaki N, Liu XG, Brodeur GM.
    Klin Padiatr; 2000 Aug 15; 212(4):200-5. PubMed ID: 10994551
    [Abstract] [Full Text] [Related]

  • 4. Brain-derived neurotrophic factor activation of TrkB protects neuroblastoma cells from chemotherapy-induced apoptosis via phosphatidylinositol 3'-kinase pathway.
    Jaboin J, Kim CJ, Kaplan DR, Thiele CJ.
    Cancer Res; 2002 Nov 15; 62(22):6756-63. PubMed ID: 12438277
    [Abstract] [Full Text] [Related]

  • 5. Truncated trkB receptors on nonneuronal cells inhibit BDNF-induced neurite outgrowth in vitro.
    Fryer RH, Kaplan DR, Kromer LF.
    Exp Neurol; 1997 Dec 15; 148(2):616-27. PubMed ID: 9417837
    [Abstract] [Full Text] [Related]

  • 6. Regulation of NGF responsiveness in human neuroblastoma.
    Bogenmann E, Peterson S, Maekawa K, Matsushima H.
    Oncogene; 1998 Nov 05; 17(18):2367-76. PubMed ID: 9811468
    [Abstract] [Full Text] [Related]

  • 7. [Blocking TrkB-BDNF signal pathway decreases the livability of neuroblastoma cells].
    Zhang JH, Li AM, Chen S, Tong HX, Zhang KR, Zhang JH.
    Zhongguo Dang Dai Er Ke Za Zhi; 2008 Feb 05; 10(1):47-50. PubMed ID: 18289471
    [Abstract] [Full Text] [Related]

  • 8. Unliganded c-erbA/thyroid hormone receptor induces trkB expression in neuroblastoma cells.
    Pastor R, Bernal J, Rodríguez-Peña A.
    Oncogene; 1994 Apr 05; 9(4):1081-9. PubMed ID: 8134111
    [Abstract] [Full Text] [Related]

  • 9. All-trans retinoic acid arrests neuroblastoma cells in a dormant state. Subsequent nerve growth factor/brain-derived neurotrophic factor treatment adds modest benefit.
    Cernaianu G, Brandmaier P, Scholz G, Ackermann OP, Alt R, Rothe K, Cross M, Witzigmann H, Tröbs RB.
    J Pediatr Surg; 2008 Jul 05; 43(7):1284-94. PubMed ID: 18639684
    [Abstract] [Full Text] [Related]

  • 10. Galectin-1 is a major effector of TrkB-mediated neuroblastoma aggressiveness.
    Cimmino F, Schulte JH, Zollo M, Koster J, Versteeg R, Iolascon A, Eggert A, Schramm A.
    Oncogene; 2009 May 14; 28(19):2015-23. PubMed ID: 19363525
    [Abstract] [Full Text] [Related]

  • 11. Developmental regulation of early serotonergic neuronal differentiation: the role of brain-derived neurotrophic factor and membrane depolarization.
    Eaton MJ, Staley JK, Globus MY, Whittemore SR.
    Dev Biol; 1995 Jul 14; 170(1):169-82. PubMed ID: 7601307
    [Abstract] [Full Text] [Related]

  • 12. Neurotrophin receptor expression in human primary retinoblastomas and retinoblastoma cell lines.
    Stephan H, Zakrzewski JL, Bölöni R, Grasemann C, Lohmann DR, Eggert A.
    Pediatr Blood Cancer; 2008 Feb 14; 50(2):218-22. PubMed ID: 17973327
    [Abstract] [Full Text] [Related]

  • 13. Resistance to chemotherapy mediated by TrkB in neuroblastomas.
    Ho R, Eggert A, Hishiki T, Minturn JE, Ikegaki N, Foster P, Camoratto AM, Evans AE, Brodeur GM.
    Cancer Res; 2002 Nov 15; 62(22):6462-6. PubMed ID: 12438236
    [Abstract] [Full Text] [Related]

  • 14. The RET and TRKA pathways collaborate to regulate neuroblastoma differentiation.
    Peterson S, Bogenmann E.
    Oncogene; 2004 Jan 08; 23(1):213-25. PubMed ID: 14712226
    [Abstract] [Full Text] [Related]

  • 15. Cutting edge: clonally restricted production of the neurotrophins brain-derived neurotrophic factor and neurotrophin-3 mRNA by human immune cells and Th1/Th2-polarized expression of their receptors.
    Besser M, Wank R.
    J Immunol; 1999 Jun 01; 162(11):6303-6. PubMed ID: 10352239
    [Abstract] [Full Text] [Related]

  • 16. An abnormal response of retinoblastoma cells (Y-79) to neurotrophins.
    Wagner N, Wagner KD, Sefton M, Rodríguez-Tébar A, Grantyn R.
    Invest Ophthalmol Vis Sci; 2000 Jun 01; 41(7):1932-9. PubMed ID: 10845619
    [Abstract] [Full Text] [Related]

  • 17. Distribution of intracerebral ventricularly administered neurotrophins in rat brain and its correlation with trk receptor expression.
    Yan Q, Matheson C, Sun J, Radeke MJ, Feinstein SC, Miller JA.
    Exp Neurol; 1994 May 01; 127(1):23-36. PubMed ID: 8200435
    [Abstract] [Full Text] [Related]

  • 18. Nicotine regulates SH-SY5Y neuroblastoma cell proliferation through the release of brain-derived neurotrophic factor.
    Serres F, Carney SL.
    Brain Res; 2006 Jul 26; 1101(1):36-42. PubMed ID: 16790237
    [Abstract] [Full Text] [Related]

  • 19. Signal transduction pathways through TRK-A and TRK-B receptors in human neuroblastoma cells.
    Sugimoto T, Kuroda H, Horii Y, Moritake H, Tanaka T, Hattori S.
    Jpn J Cancer Res; 2001 Feb 26; 92(2):152-60. PubMed ID: 11223544
    [Abstract] [Full Text] [Related]

  • 20. HMGI(Y) and HMGI-C genes are expressed in neuroblastoma cell lines and tumors and affect retinoic acid responsiveness.
    Giannini G, Di Marcotullio L, Ristori E, Zani M, Crescenzi M, Scarpa S, Piaggio G, Vacca A, Peverali FA, Diana F, Screpanti I, Frati L, Gulino A.
    Cancer Res; 1999 May 15; 59(10):2484-92. PubMed ID: 10344762
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.